left atrial appendage closureradiofrequency ablation
left atrial appendage closure: Patients with atrial fibrillation underwent transcatheter radiofrequency cardiac ablation 1 month after left atrial appendage closure with WATCHMAN FLX
radiofrequency ablation: Patients with atrial fibrillation underwent transcatheter radiofrequency cardiac ablation 1 month after left atrial appendage closure with WATCHMAN FLX
Study summary
Objective: To evaluate the safety and efficacy of transcatheter atrial fibrillation ablation 1 month after WATCHMAN FLX left atrial appendage closure in patients with nonvalvular atrial fibrillation.
Eligibility
Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria:
1. ≥18 years of age, diagnosed with nonvalvular atrial fibrillation;
2. Meet the indications for receiving WATCHMAN FLX left atrial appendicular closure and transcatheter atrial fibrillation ablation;
3. Preoperative imaging evaluation showed that the anatomical structure of the left atrial appendage was suitable for implantation with the WATCHMAN FLX device;
4. The patient agrees to participate in the study and signs the informed consent.
Exclusion Criteria:
1. valvular heart disease or other structural heart disease that causes atrial fibrillation;
2. left auricular thrombus or acute thrombotic event was found before surgery;
3. Patients with severe bleeding tendency or recent major bleeding events (such as massive gastrointestinal bleeding, cerebral hemorrhage, etc.);
4. Patients who are unable to complete postoperative follow-up (such as life expectancy of less than 1 year or poor compliance);
5. Other serious diseases (such as liver and kidney failure, active infection, etc.) were found in preoperative examination;
6. Pregnant or lactating women.
Primary outcome measure(s)
Treatment success at one year — one year The success rate of complete left atrial appendage closure within 12 months post-WATCHMAN FLX left atrial appendage occlusion surgery, as evaluated by contrast-enhanced computed tomography angiography (CTA) of the left atrial appendage.
Trial sites (1)
Facility
City
Region
Status
Affiliated hospital of Nantong University
Nantong
Jiangsu
Recruiting
More Affiliated Hospital of Nantong University trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.